PROVIDER PROFILE · NPI 1053378083

Tannaz MonteeMD

Pulmonary DiseaseKansas City, MOI
PRESCRIBING · PART D · 2024
Total Rx claims
57
Beneficiaries
Total drug cost
$21K
Distinct drugs
3
Brand share
59.6%
Top prescribed drugs
QUALITY · MIPS · 2024
Final MIPS score
78.9
Quality
50.3
Cost
81.2
Improvement activities
40.0
Promoting interop.
90.0
Payment adjustment
0.16%
Group
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital